Optimizing measurement of EGFR mutation status in NSCLC

被引：0
|
作者：
Nicolson, M.
Clark, C.
Bell, C.
Osborne, A.
Tracey, J.
Petty, R. D.
Kerr, K. M.
机构：
[1] Aberdeen Royal Infirm, Aberdeen, Scotland
[2] Univ Aberdeen, Aberdeen, Scotland
[3] Univ Aberdeen, Aberdeen Royal Infirm, Aberdeen, Scotland
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.e18120
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18120
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Radiomics signature: A potential and incremental predictor for EGFR mutation status in NSCLC patients, comparison with CT morphology
    Tu, Wenting
    Sun, Guangyuan
    Fan, Li
    Wang, Yun
    Xia, Yi
    Guan, Yu
    Li, Qiong
    Zhang, Di
    Liu, Shiyuan
    Li, Zhaobin
    [J]. LUNG CANCER, 2019, 132 : 28 - 35
  • [42] Diagnosis and Monitoring of EGFR Mutation Status with cfDNA in Advanced NSCLC: A Prospective Single Institution Study in Asia
    Chou, T.
    Ho, H.
    Chiu, C.
    Tsai, C.
    Das, P. M.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2253 - S2253
  • [43] Circulating plasma miRNAs expression alterations as promising marker in discrimination of EGFR mutation status in NSCLC patients
    Florczuk, M.
    Szpechcinski, A.
    Duk, K.
    Komorowski, M.
    Kupis, W.
    Rudzinski, P.
    Bryl, M.
    Orlowski, T.
    Chorostowska-Wynimko, J.
    [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 445 - 446
  • [44] Tumor Tissue and Plasma EGFR Exon 20 Insertion Mutation Status in NSCLC Patients Treated with Sunvozertinib
    Wang, M.
    Fan, Y.
    Sun, M.
    Wang, Y.
    Zhao, Y.
    Jin, B.
    Hu, Y.
    Han, Z.
    Song, X.
    Liu, A.
    Tang, K.
    Ding, C.
    Liang, L.
    Wu, L.
    Gao, J.
    Wang, J.
    Cheng, Y.
    Zhou, J.
    He, Y.
    Dong, X.
    Yao, Y.
    Yu, Y.
    Wang, H.
    Sun, S.
    Huang, J.
    Fang, J.
    Li, W.
    Wang, L.
    Ren, X.
    Zhou, C.
    Hu, Y.
    Zhao, D.
    Yang, R.
    Xu, F.
    Huang, Y.
    Pan, Y.
    Cui, J.
    Xu, Y.
    Zhu, X.
    Shi, Y.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S150 - S150
  • [45] Activating IDH Mutation as Resistance Mechanism to EGFR TKI in EGFR plus NSCLC
    Chen, S.
    Zhu, H.
    Jin, M.
    Liu, Z.
    Li, J.
    Hong, C.
    Li, T.
    Zhu, X.
    Meng, L.
    Qi, D.
    Zhang, X.
    Ma, T.
    Dong, L.
    Teng, L.
    Li, X.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S681 - S682
  • [46] Influence of chemotherapy on EGFR mutation status
    Luo, Yung-Hung
    Chen, Yuh-Min
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2013, 2 (06) : 442 - 444
  • [47] Combined radiomics of primary tumour and bone metastasis improve the prediction of EGFR mutation status and response to EGFR-TKI therapy for NSCLC
    Cheng, Yuan
    Wang, Huan
    Yuan, Wendi
    Wang, Haotian
    Zhu, Yuheng
    Chen, Huanhuan
    Jiang, Wenyan
    [J]. PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 2023, 116
  • [48] EGFR mutation analysis from the German REASON study - a registry for the epidemiologic and scientific evaluation of EGFR mutation status in newly diagnosed NSCLC patients stage IIIB/IV
    Schuette, W.
    Eberhardt, W.
    von der Schulenburg, Graf J. M.
    Dietel, M.
    Schirmacher, P.
    Fischer, J. R.
    Mezger, J.
    Schumann, C.
    Serke, M.
    Zaun, S.
    Thomas, M.
    [J]. ONKOLOGIE, 2012, 35 : 36 - 36
  • [49] EGFR mutation detection in NSCLC-assessment of diagnostic application and recommendations of the German Panel for Mutation Testing in NSCLC
    Penzel, Roland
    Sers, Christine
    Chen, Yuan
    Lehmann-Muehlenhoff, Ulrich
    Merkelbach-Bruse, Sabine
    Jung, Andreas
    Kirchner, Thomas
    Buettner, Reinhard
    Kreipe, Hans H.
    Petersen, Iver
    Dietel, Manfred
    Schirmacher, Peter
    [J]. VIRCHOWS ARCHIV, 2011, 458 (01) : 95 - 98
  • [50] Relevance of performance status as a prognosticator in EGFR mutant NSCLC
    Noronha, V.
    Prabhash, K.
    Joshi, A.
    Patil, V.
    Chougule, A.
    Kaushal, R.
    Jambhekar, N.
    Tandon, N.
    Philip, D. S.
    [J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 : S613 - S613
12345